Patents by Inventor Alexander V. GALAZYUK

Alexander V. GALAZYUK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of tinnitus using glutamate receptor agonists
    Patent number: 11938106
    Abstract: A method of treating tinnitus in a subject is described that includes administering a therapeutically effective amount of a group II metabotropic glutamate receptor (mGluR) agonist to the subject. A method of screening a subject having tinnitus for treatment with a group II mGluR agonist that includes testing the use of residual inhibition to suppress tinnitus in the subject, wherein suppression of tinnitus by residual inhibition indicates that a group II mGluR agonist would be effective for treating tinnitus in the subject, is also described.
    Type: Grant
    Filed: April 18, 2022
    Date of Patent: March 26, 2024
    Assignee: NORTHEAST OHIO MEDICAL UNIVERSITY
    Inventor: Alexander V. Galazyuk
  • TREATMENT OF TINNITUS USING GLUTAMATE RECEPTOR AGONISTS
    Publication number: 20230038631
    Abstract: A method of treating tinnitus in a subject is described that includes administering a therapeutically effective amount of a group II metabotropic glutamate receptor (mGluR) agonist to the subject. A method of screening a subject having tinnitus for treatment with a group II mGluR agonist that includes testing the use of residual inhibition to suppress tinnitus in the subject, wherein suppression of tinnitus by residual inhibition indicates that a group II mGluR agonist would be effective for treating tinnitus in the subject, is also described.
    Type: Application
    Filed: April 18, 2022
    Publication date: February 9, 2023
    Inventor: Alexander V. GALAZYUK
  • Treatment of tinnitus using glutamate receptor agonists
    Patent number: 11304917
    Abstract: A method of treating tinnitus in a subject is described that includes administering a therapeutically effective amount of a group II metabotropic glutamate receptor (mGluR) agonist to the subject. A method of screening a subject having tinnitus for treatment with a group II mGluR agonist that includes testing the use of residual inhibition to suppress tinnitus in the subject, wherein suppression of tinnitus by residual inhibition indicates that a group II mGluR agonist would be effective for treating tinnitus in the subject, is also described.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: April 19, 2022
    Assignee: NORTHEAST OHIO MEDICAL UNIVERSITY
    Inventor: Alexander V. Galazyuk
  • TREATMENT OF TINNITUS USING GLUTAMATE RECEPTOR AGONISTS
    Publication number: 20210251928
    Abstract: A method of treating tinnitus in a subject is described that includes administering a therapeutically effective amount of a group II metabotropic glutamate receptor (mGluR) agonist to the subject. A method of screening a subject having tinnitus for treatment with a group II mGluR agonist that includes testing the use of residual inhibition to suppress tinnitus in the subject, wherein suppression of tinnitus by residual inhibition indicates that a group II mGluR agonist would be effective for treating tinnitus in the subject, is also described.
    Type: Application
    Filed: February 19, 2016
    Publication date: August 19, 2021
    Inventor: Alexander V. GALAZYUK